.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
UBS
Deloitte
Chinese Patent Office
Novartis
Farmers Insurance
US Department of Justice
Daiichi Sankyo
Johnson and Johnson
Federal Trade Commission

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020527

« Back to Dashboard

NDA 020527 describes PREMPRO, which is a drug marketed by Wyeth Pharms Inc and is included in two NDAs. It is available from four suppliers. Additional details are available on the PREMPRO profile page.

The generic ingredient in PREMPRO is estrogens, conjugated; medroxyprogesterone acetate. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the estrogens, conjugated; medroxyprogesterone acetate profile page.

Summary for 020527

Tradename:2
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 020527

Suppliers and Packaging for NDA: 020527

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PREMPHASE 14/14 estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527 NDA Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. 0046-1105 0046-1105-11 1 BLISTER PACK in 1 CARTON (0046-1105-11) > 28 TABLET, SUGAR COATED in 1 BLISTER PACK
PREMPHASE 14/14 estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527 NDA Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. 0046-1105 0046-1105-51 1 POUCH in 1 CARTON (0046-1105-51) > 1 BLISTER PACK in 1 POUCH > 5 TABLET, SUGAR COATED in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.625MG;2.5MG
Approval Date:Nov 17, 1995TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.625MG,0.625MG;N/A,5MG
Approval Date:Nov 17, 1995TE:RLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.625MG;5MG
Approval Date:Jan 9, 1998TE:RLD:Yes

Expired Orange Book Patents for NDA: 020527

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms IncPREMPROestrogens, conjugated; medroxyprogesterone acetateTABLET;ORAL-28020527-003Jan 9, 1998► Subscribe► Subscribe
Wyeth Pharms IncPREMPROestrogens, conjugated; medroxyprogesterone acetateTABLET;ORAL-28020527-004Mar 12, 2003► Subscribe► Subscribe
Wyeth Pharms IncPREMPROestrogens, conjugated; medroxyprogesterone acetateTABLET;ORAL-28020527-003Jan 9, 1998► Subscribe► Subscribe
Wyeth Pharms IncPREMPROestrogens, conjugated; medroxyprogesterone acetateTABLET;ORAL-28020527-001Nov 17, 1995► Subscribe► Subscribe
Wyeth Pharms IncPREMPHASE 14/14estrogens, conjugated; medroxyprogesterone acetateTABLET;ORAL-28020527-002Nov 17, 1995► Subscribe► Subscribe
Wyeth Pharms IncPREMPROestrogens, conjugated; medroxyprogesterone acetateTABLET;ORAL-28020527-004Mar 12, 2003► Subscribe► Subscribe
Wyeth Pharms IncPREMPROestrogens, conjugated; medroxyprogesterone acetateTABLET;ORAL-28020527-001Nov 17, 1995► Subscribe► Subscribe
Wyeth Pharms IncPREMPROestrogens, conjugated; medroxyprogesterone acetateTABLET;ORAL-28020527-004Mar 12, 2003► Subscribe► Subscribe
Wyeth Pharms IncPREMPROestrogens, conjugated; medroxyprogesterone acetateTABLET;ORAL-28020527-005Jun 4, 2003► Subscribe► Subscribe
Wyeth Pharms IncPREMPROestrogens, conjugated; medroxyprogesterone acetateTABLET;ORAL-28020527-005Jun 4, 2003► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Daiichi Sankyo
UBS
Express Scripts
Queensland Health
Johnson and Johnson
AstraZeneca
Dow
US Army
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot